Federal contractor profile
Leidos Biomedical Research: Federal Contracts, Agencies & Awards
Data through 2026-09-08 · FY2026 to date
- Obligations, FY2026 to date
- $303M
- Contract awards
- 105
- Average award size
- $2.9M
- vs. prior full fiscal year
- 45.9% decline
| Item | Obligations |
|---|---|
| FY21 | $935M |
| FY22 | $982M |
| FY23 | $1.2B |
| FY24 | $869M |
| FY25 | $560M |
| FY26 | $303M |
Obligations fell 45.9% year over year, from $560M in FY2025 to $303M in FY2026 to date.
Leidos Biomedical Research has $303M in federal contract obligations for FY2026 to date across 105 awards. The average award size is $2.9M. Obligations fell down 45.9% year over year. Historical obligations were $935M in FY21, $982M in FY22, $1.2B in FY23, $869M in FY24, and $560M in FY25, showing the recent decline ahead of the current partial total. The largest listed NAICS market entry is Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) at $305M. The rankings also list Facilities Support Services as a top NAICS market for FY2026 to date. The note clarifies that all figures are contract obligations except award-value figures in the largest-awards and expiring-contracts tables, which are total contract values. Use these figures to monitor scale, award counts, and market concentration for Leidos Biomedical Research in FY2026 to date.
How do FY2026 obligations compare with prior fiscal years?
Leidos Biomedical Research obligated $303M in FY2026 to date. Leidos Biomedical Research recorded $935M in FY21, $982M in FY22, $1.2B in FY23, $869M in FY24, and $560M in FY25. Leidos Biomedical Research obligations fell down 45.9% year over year and the FY2026 total is a partial fiscal year to date figure.
| Item | Obligations |
|---|---|
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | $305M |
| Facilities Support Services | -$2.1M |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) is Leidos Biomedical Research's largest federal market, with $305M in obligations.
What are the top markets for Leidos Biomedical Research in FY2026 to date?
Leidos Biomedical Research shows Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) at $305M. Leidos Biomedical Research also lists Facilities Support Services among the top NAICS markets for FY2026 to date. These entries indicate market concentration and the principal service categories reflected in obligations.
| Rank | Award | Award Amount | Awarding Agency | Ends |
|---|---|---|---|---|
| 1 | HHSN261200800001E | $4.8B | Department of Health and Human Services | 2024-09-06 |
| 2 | 75N91020F00003 | $1.8B | Department of Health and Human Services | 2024-09-27 |
| 3 | 75N91025F00016 | $485M | Department of Health and Human Services | 2027-08-30 |
| 4 | 75N91019F00129 | $432M | Department of Health and Human Services | 2026-05-21 |
| 5 | 75N91020F00039 | $234M | Department of Health and Human Services | 2029-09-29 |
| 6 | 75N91019F00139 | $181M | Department of Health and Human Services | 2029-10-31 |
| 7 | 75N91023F00008 | $173M | Department of Health and Human Services | 2029-05-31 |
| 8 | 75N91021F00004 | $142M | Department of Health and Human Services | 2031-01-28 |
| 9 | 75N91019F00133 | $126M | Department of Health and Human Services | 2024-08-30 |
| 10 | 75N91020F00006 | $122M | Department of Health and Human Services | 2024-08-30 |
| 11 | 75N91021F00013 | $92.1M | Department of Health and Human Services | 2028-02-28 |
| 12 | 75N91025F00014 | $87.8M | Department of Health and Human Services | 2027-08-30 |
| 13 | 75N91021F00001 | $79.9M | Department of Health and Human Services | 2026-10-31 |
| 14 | 75N91025F00012 | $77.6M | Department of Health and Human Services | 2026-08-30 |
| 15 | 75N91019F00130 | $63.1M | Department of Health and Human Services | 2020-08-30 |
| 16 | 75N91020F00021 | $45.9M | Department of Health and Human Services | 2030-08-31 |
| 17 | 75N91020F00030 | $37.7M | Department of Health and Human Services | 2027-08-30 |
| 18 | 75N91019F00134 | $32.7M | Department of Health and Human Services | 2026-09-30 |
| 19 | 75N91025F00005 | $28.5M | Department of Health and Human Services | 2026-08-30 |
| 20 | HHSN26100019 | $27.5M | Department of Health and Human Services | 2021-09-18 |
| 21 | 75N91024F00027 | $27M | Department of Health and Human Services | 2025-08-30 |
| 22 | 75N91022F00013 | $25.1M | Department of Health and Human Services | 2030-06-17 |
| 23 | 75N91019F00138 | $24.1M | Department of Health and Human Services | 2029-09-18 |
| 24 | 75N91022F00019 | $22.4M | Department of Health and Human Services | 2027-09-08 |
| 25 | 75N91021F00017 | $21.7M | Department of Health and Human Services | 2029-08-21 |
| Award | Awarding Agency | Award Value | Ends |
|---|---|---|---|
| 75N91025F00016 | Department of Health and Human Services | $485M | 2027-08-30 |
| 75N91025F00014 | Department of Health and Human Services | $87.8M | 2027-08-30 |
| 75N91021F00001 | Department of Health and Human Services | $79.9M | 2026-10-31 |
| 75N91018F00071 | Department of Health and Human Services | $67M | 2027-08-31 |
| 75N91020F00026 | Department of Health and Human Services | $56.5M | 2027-05-25 |
| 75N91020F00030 | Department of Health and Human Services | $37.7M | 2027-08-30 |
| 75N91019F00134 | Department of Health and Human Services | $32.7M | 2026-09-30 |
| 75N91022F00019 | Department of Health and Human Services | $22.4M | 2027-09-08 |
| 75N91021F00015 | Department of Health and Human Services | $20.4M | 2027-04-30 |
| HHSN26100039 | Department of Health and Human Services | $19.8M | 2026-09-30 |
| Detail | Registration |
|---|---|
| Unique Entity ID (UEI) | HV8BH9BPG8Y9 |
| Headquarters | Frederick, MD |
| Parent company | LEIDOS HOLDINGS, INC. |
| Business types | Category business; Corporate entity not tax exempt; Other than small business; Special designations; Us owned business |
This is the free layer.
GovHub customers get the live version, filters, exports, and AI proposal drafting on top of this data.
No credit card required · 14-day free trial
Frequently asked questions
How much does Leidos Biomedical Research make from federal contracts?
Leidos Biomedical Research made $303M from federal contracts in FY2026 to date. Leidos Biomedical Research received 105 awards in the period, with an average award size of $2.9M, and obligations fell down 45.9% year over year.
Which agencies buy from Leidos Biomedical Research?
Leidos Biomedical Research sells to federal agencies through 105 awards totaling $303M in FY2026 to date. The summary page does not list specific agency names on the summary, only award count and obligations for the fiscal year to date.
What does Leidos Biomedical Research sell to the government?
Leidos Biomedical Research sells research and development services and related support to the government. The top NAICS entry is Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) at $305M, and Facilities Support Services is also listed among top NAICS markets for FY2026 to date.
Which Leidos Biomedical Research contracts are expiring soon?
Leidos Biomedical Research has no expiring-contract details on the summary page. The note states that largest-awards and expiring-contracts tables report total contract values, but the summary does not provide specific expiring-contract entries.
Found your market? GovHub writes the proposal.
Turn this market intelligence into a submitted, compliant federal proposal, faster.
No credit card required · 14-day free trial